Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 175

1.

Identification of Marek's Disease Virus VP22 Tegument Protein Domains Essential for Virus Cell-to-Cell Spread, Nuclear Localization, Histone Association and Cell-Cycle Arrest.

Trapp-Fragnet L, Courvoisier K, Rémy S, Pape GL, Loustalot F, Denesvre C.

Viruses. 2019 Jun 8;11(6). pii: E537. doi: 10.3390/v11060537.

2.

Perceptions of insulin therapy in people with type 2 diabetes and physicians: a cross-sectional survey conducted in France.

Cosson E, Mauchant C, Benabbad I, Le Pape G, Le Bleis M, Bailleul F, Lalau JD.

Patient Prefer Adherence. 2019 Feb 11;13:251-260. doi: 10.2147/PPA.S181363. eCollection 2019.

3.

Comparison of Dental Students' Perceived Value of Faculty vs. Peer Feedback on Non-Technical Clinical Competency Assessments.

Andrews E, Dickter DN, Stielstra S, Pape G, Aston SJ.

J Dent Educ. 2019 May;83(5):536-545. doi: 10.21815/JDE.019.056. Epub 2019 Feb 25.

PMID:
30804169
4.

Assessing the Professional Identity of Dental School Faculty: An Exploratory Study.

Pape G, Dong F, Horvath Z.

J Dent Educ. 2018 Nov;82(11):1140-1145. doi: 10.21815/JDE.018.117.

PMID:
30385679
5.

Multidisciplinary COPD disease management program: impact on clinical outcomes.

Morganroth M, Pape G, Rozenfeld Y, Heffner JE.

Postgrad Med. 2016;128(2):239-49. doi: 10.1080/00325481.2016.1129259. Epub 2015 Dec 22.

PMID:
26641555
6.

[Prostheses for fractures of the proximal humerus: presentation of current results of anatomical fracture shoulder prosthesis under consideration of alternative concepts].

Pape G, Tonne L, Raiss P, Loew M, Zeifang F.

Orthopade. 2013 Mar;42(3):164-9. doi: 10.1007/s00132-012-2059-8. German.

PMID:
23455315
7.

Results of cemented total shoulder replacement with a minimum follow-up of ten years.

Raiss P, Schmitt M, Bruckner T, Kasten P, Pape G, Loew M, Zeifang F.

J Bone Joint Surg Am. 2012 Dec 5;94(23):e1711-10. doi: 10.2106/JBJS.K.00580.

PMID:
23224391
8.

Shoulder hemiarthroplasty: outcomes and long-term survival analysis according to etiology.

Gadea F, Alami G, Pape G, Boileau P, Favard L.

Orthop Traumatol Surg Res. 2012 Oct;98(6):659-65. doi: 10.1016/j.otsr.2012.03.020. Epub 2012 Sep 1.

9.

Treatment of severe cuff tear arthropathy with the humeral head resurfacing arthroplasty: two-year minimum follow-up.

Pape G, Bruckner T, Loew M, Zeifang F.

J Shoulder Elbow Surg. 2013 Jan;22(1):e1-7. doi: 10.1016/j.jse.2012.04.006. Epub 2012 Jun 26.

PMID:
22743073
10.

Secondary rotator cuff dysfunction following total shoulder arthroplasty for primary glenohumeral osteoarthritis: results of a multicenter study with more than five years of follow-up.

Young AA, Walch G, Pape G, Gohlke F, Favard L.

J Bone Joint Surg Am. 2012 Apr 18;94(8):685-93. doi: 10.2106/JBJS.J.00727.

PMID:
22419408
11.

Team-based care approach to cholesterol management in diabetes mellitus: two-year cluster randomized controlled trial.

Pape GA, Hunt JS, Butler KL, Siemienczuk J, LeBlanc BH, Gillanders W, Rozenfeld Y, Bonin K.

Arch Intern Med. 2011 Sep 12;171(16):1480-6. doi: 10.1001/archinternmed.2011.417.

PMID:
21911633
12.

Bone cement penetration pattern and primary stability testing in keeled and pegged glenoid components.

Raiss P, Pape G, Kleinschmidt K, Jäger S, Sowa B, Jakubowitz E, Loew M, Bruckner T, Rickert M.

J Shoulder Elbow Surg. 2011 Jul;20(5):723-31. doi: 10.1016/j.jse.2010.09.006. Epub 2010 Dec 30.

PMID:
21194976
13.

Humeral surface replacement for the sequelae of fractures of the proximal humerus.

Pape G, Zeifang F, Bruckner T, Raiss P, Rickert M, Loew M.

J Bone Joint Surg Br. 2010 Oct;92(10):1403-9. doi: 10.1302/0301-620X.92B10.24316.

PMID:
20884979
14.

[Significance of bone mineral density and modern cementing technique for in vitro cement penetration in total shoulder arthroplasty].

Pape G, Raiss P, Kleinschmidt K, Schuld C, Mohr G, Loew M, Rickert M.

Z Orthop Unfall. 2010 Dec;148(6):680-4. doi: 10.1055/s-0030-1249986. Epub 2010 Jun 18. German.

PMID:
20563970
15.

In vitro measurement of temperature changes during implantation of cemented glenoid components.

Raiss P, Pape G, Jäger S, Loew M, Bitsch R, Rickert M.

Acta Orthop. 2010 Apr;81(2):211-5. doi: 10.3109/17453671003717823. Erratum in: Acta Orthop. 2010 Oct; 81(5):647.

16.

Mid-term survivorship analysis of a shoulder replacement with a keeled glenoid and a modern cementing technique.

Kasten P, Pape G, Raiss P, Bruckner T, Rickert M, Zeifang F, Loew M.

J Bone Joint Surg Br. 2010 Mar;92(3):387-92. doi: 10.1302/0301-620X.92B3.23073.

PMID:
20190310
17.

[Comparison of short-term results after CUP prosthesis with cemented glenoid components and total shoulder arthroplasty: a matched-pair analysis].

Pape G, Raiss P, Aldinger PR, Loew M.

Z Orthop Unfall. 2010 Dec;148(6):674-9. doi: 10.1055/s-0029-1186202. Epub 2009 Oct 19. German.

PMID:
20135592
18.

The impact of a physician-directed health information technology system on diabetes outcomes in primary care: a pre- and post-implementation study.

Hunt JS, Siemienczuk J, Gillanders W, LeBlanc BH, Rozenfeld Y, Bonin K, Pape G.

Inform Prim Care. 2009;17(3):165-74.

19.

[Cementless humeral surface replacement arthroplasty in patients less than 55 years of age].

Raiss P, Pape G, Becker S, Rickert M, Loew M.

Orthopade. 2010 Feb;39(2):201-8. doi: 10.1007/s00132-009-1525-4. German.

PMID:
19768450
20.

Economic evaluation of early monotherapy versus delayed monotherapy or combination therapy in patients with acute hepatitis C in Germany.

Dintsios CM, Haverkamp A, Wiegand J, Gerlach T, Wedemeyer H, Pape G, Manns MP, Krauth C.

Eur J Gastroenterol Hepatol. 2010 Mar;22(3):278-88. doi: 10.1097/MEG.0b013e32832c7b2e.

PMID:
19550347
21.

Breakpoint regions and homologous synteny blocks in chromosomes have different evolutionary histories.

Larkin DM, Pape G, Donthu R, Auvil L, Welge M, Lewin HA.

Genome Res. 2009 May;19(5):770-7. doi: 10.1101/gr.086546.108. Epub 2009 Apr 2.

22.

A randomized controlled trial of team-based care: impact of physician-pharmacist collaboration on uncontrolled hypertension.

Hunt JS, Siemienczuk J, Pape G, Rozenfeld Y, MacKay J, LeBlanc BH, Touchette D.

J Gen Intern Med. 2008 Dec;23(12):1966-72. doi: 10.1007/s11606-008-0791-x. Epub 2008 Sep 25.

23.

Tracking virus-specific CD4+ T cells during and after acute hepatitis C virus infection.

Lucas M, Ulsenheimer A, Pfafferot K, Heeg MH, Gaudieri S, Grüner N, Rauch A, Gerlach JT, Jung MC, Zachoval R, Pape GR, Schraut W, Santantonio T, Nitschko H, Obermeier M, Phillips R, Scriba TJ, Semmo N, Day C, Weber JN, Fidler S, Thimme R, Haberstroh A, Baumert TF, Klenerman P, Diepolder HM.

PLoS One. 2007 Jul 25;2(7):e649.

24.

Efficacy of amantadine on quality of life in patients with chronic hepatitis C treated with interferon-alpha and ribavirin: results from a randomized, placebo-controlled, double-blind trial.

Kronenberger B, Berg T, Herrmann E, Hinrichsen H, Gerlach T, Buggisch P, Spengler U, Goeser T, Nasser S, Wursthorn K, Pape GR, Hopf U, Zeuzem S.

Eur J Gastroenterol Hepatol. 2007 Aug;19(8):639-46.

PMID:
17625432
25.

Characterization of sequence variations in immunodominant regions of the HBV-nucleocapsid protein as a prerequisite for the development of an epitope-based vaccine.

Gruener NH, Gerlach TJ, Ulsenheimer A, Diepolder HM, Wierenga E, Zachoval R, Heeg M, Pape GR, Jung MC.

Vaccine. 2007 Jun 21;25(26):4960-6. Epub 2006 Dec 22.

PMID:
17466417
26.

Late-acting dominant lethal genetic systems and mosquito control.

Phuc HK, Andreasen MH, Burton RS, Vass C, Epton MJ, Pape G, Fu G, Condon KC, Scaife S, Donnelly CA, Coleman PG, White-Cooper H, Alphey L.

BMC Biol. 2007 Mar 20;5:11.

27.

Vaccine-induced early control of hepatitis C virus infection in chimpanzees fails to impact on hepatic PD-1 and chronicity.

Rollier CS, Paranhos-Baccala G, Verschoor EJ, Verstrepen BE, Drexhage JA, Fagrouch Z, Berland JL, Komurian-Pradel F, Duverger B, Himoudi N, Staib C, Meyr M, Whelan M, Whelan JA, Adams VC, Larrea E, Riezu JI, Lasarte JJ, Bartosch B, Cosset FL, Spaan WJ, Diepolder HM, Pape GR, Sutter G, Inchauspe G, Heeney JL.

Hepatology. 2007 Mar;45(3):602-13. Erratum in: Hepatology. 2007 Jun;45(6):1590. Adams, Victoria A [corrected to Adams, Victoria C]; Lasarte, Juan José [corrected to Lasarte, Juan J].

PMID:
17326154
28.

Transient immunological control during acute hepatitis C virus infection: ex vivo analysis of helper T-cell responses.

Ulsenheimer A, Lucas M, Seth NP, Tilman Gerlach J, Gruener NH, Loughry A, Pape GR, Wucherpfennig KW, Diepolder HM, Klenerman P.

J Viral Hepat. 2006 Oct;13(10):708-14.

29.

Extended treatment duration for hepatitis C virus type 1: comparing 48 versus 72 weeks of peginterferon-alfa-2a plus ribavirin.

Berg T, von Wagner M, Nasser S, Sarrazin C, Heintges T, Gerlach T, Buggisch P, Goeser T, Rasenack J, Pape GR, Schmidt WE, Kallinowski B, Klinker H, Spengler U, Martus P, Alshuth U, Zeuzem S.

Gastroenterology. 2006 Apr;130(4):1086-97.

PMID:
16618403
30.

Relation between homocysteine and biochemical bone turnover markers and bone mineral density in peri- and post-menopausal women.

Herrmann M, Kraenzlin M, Pape G, Sand-Hill M, Herrmann W.

Clin Chem Lab Med. 2005;43(10):1118-23.

PMID:
16197308
31.

Minimal T-cell-stimulatory sequences and spectrum of HLA restriction of immunodominant CD4+ T-cell epitopes within hepatitis C virus NS3 and NS4 proteins.

Gerlach JT, Ulsenheimer A, Grüner NH, Jung MC, Schraut W, Schirren CA, Heeg M, Scholz S, Witter K, Zahn R, Vogler A, Zachoval R, Pape GR, Diepolder HM.

J Virol. 2005 Oct;79(19):12425-33.

32.

Dynamics of mammalian chromosome evolution inferred from multispecies comparative maps.

Murphy WJ, Larkin DM, Everts-van der Wind A, Bourque G, Tesler G, Auvil L, Beever JE, Chowdhary BP, Galibert F, Gatzke L, Hitte C, Meyers SN, Milan D, Ostrander EA, Pape G, Parker HG, Raudsepp T, Rogatcheva MB, Schook LB, Skow LC, Welge M, Womack JE, O'brien SJ, Pevzner PA, Lewin HA.

Science. 2005 Jul 22;309(5734):613-7.

33.

Plasmacytoid dendritic cells in acute and chronic hepatitis C virus infection.

Ulsenheimer A, Gerlach JT, Jung MC, Gruener N, Wächtler M, Backmund M, Santantonio T, Schraut W, Heeg MH, Schirren CA, Zachoval R, Pape GR, Diepolder HM.

Hepatology. 2005 Mar;41(3):643-51.

PMID:
15726647
34.

Evaluation of alkaline phosphatase activity assay for the Reflotron system after substitution of the comparison method.

Hübner U, Pape G, Lotz J, Bertsch T, Kraft M, Geisel J, Herrmann W.

Clin Lab. 2005;51(1-2):49-53.

PMID:
15719705
35.

Uptake and presentation of hepatitis C virus-like particles by human dendritic cells.

Barth H, Ulsenheimer A, Pape GR, Diepolder HM, Hoffmann M, Neumann-Haefelin C, Thimme R, Henneke P, Klein R, Paranhos-Baccalà G, Depla E, Liang TJ, Blum HE, Baumert TF.

Blood. 2005 May 1;105(9):3605-14. Epub 2005 Jan 18.

PMID:
15657184
36.

Analysis of a successful HCV-specific CD8+ T cell response in patients with recurrent HCV-infection after orthotopic liver transplantation.

Gruener NH, Jung MC, Ulsenheimer A, Gerlach JT, Zachoval R, Diepolder HM, Baretton G, Schauer R, Pape GR, Schirren CA.

Liver Transpl. 2004 Dec;10(12):1487-96.

37.
38.

Inhibition of hepatitis C virus-like particle binding to target cells by antiviral antibodies in acute and chronic hepatitis C.

Steinmann D, Barth H, Gissler B, Schürmann P, Adah MI, Gerlach JT, Pape GR, Depla E, Jacobs D, Maertens G, Patel AH, Inchauspé G, Liang TJ, Blum HE, Baumert TF.

J Virol. 2004 Sep;78(17):9030-40.

39.

Antiviral treatment of recurrent hepatitis C virus (HCV) infection after liver transplantation: association of a strong, multispecific, and long-lasting CD4+ T cell response with HCV-elimination.

Schirren CA, Zachoval R, Gerlach JT, Ulsenheimer A, Gruener NH, Diepolder HM, Baretton G, Schraut W, Rau HG, Nitschko H, Pape GR, Jung MC.

J Hepatol. 2003 Sep;39(3):397-404.

PMID:
12927926
40.

Acute hepatitis C: high rate of both spontaneous and treatment-induced viral clearance.

Gerlach JT, Diepolder HM, Zachoval R, Gruener NH, Jung MC, Ulsenheimer A, Schraut WW, Schirren CA, Waechtler M, Backmund M, Pape GR.

Gastroenterology. 2003 Jul;125(1):80-8.

PMID:
12851873
41.

Triple therapy with amantadine in treatment-naive patients with chronic hepatitis C: a placebo-controlled trial.

Berg T, Kronenberger B, Hinrichsen H, Gerlach T, Buggisch P, Herrmann E, Spengler U, Goeser T, Nasser S, Wursthorn K, Pape GR, Hopf U, Zeuzem S.

Hepatology. 2003 Jun;37(6):1359-67.

PMID:
12774015
42.

[Hepatitis C virus infection 2003 from the point of view of a hepatologist].

Pape GR.

Anaesthesist. 2003 May;52(5):456-8. Review. German. No abstract available.

PMID:
12750831
43.

Detection of functionally altered hepatitis C virus-specific CD4 T cells in acute and chronic hepatitis C.

Ulsenheimer A, Gerlach JT, Gruener NH, Jung MC, Schirren CA, Schraut W, Zachoval R, Pape GR, Diepolder HM.

Hepatology. 2003 May;37(5):1189-98.

PMID:
12717401
44.

[21-year-old patient with recurrent diarrhea, weight loss, leg edema and iron deficiency. Gluten sensitive sprue].

Schäfer C, Pape GR, Göke B.

Internist (Berl). 2002 Nov;43(11):1459-63. German. No abstract available.

PMID:
12524925
45.

Hepatitis C virus eradication associated with hepatitis B virus superinfection and development of a hepatitis B virus specific T cell response.

Gruener NH, Jung MC, Ulsenheimer A, Gerlach TJ, Diepolder HM, Schirren CA, Hoffmann R, Wächtler M, Backmund M, Pape GR.

J Hepatol. 2002 Dec;37(6):866-9.

PMID:
12445431
46.

Sickle cell disease, extreme hyperbilirubinemia, and pericardial tamponade: case report and review of the literature.

Khurshid I, Anderson L, Downie GH, Pape GS.

Crit Care Med. 2002 Oct;30(10):2363-7. Review.

PMID:
12394969
47.

Measurement of serum beta-crosslaps is influenced by proteolytic conditions.

Herrmann M, Pape G, Herrmann W.

Clin Chem Lab Med. 2002 Aug;40(8):790-4.

PMID:
12392306
48.

Immunological monitoring during therapeutic vaccination as a prerequisite for the design of new effective therapies: induction of a vaccine-specific CD4+ T-cell proliferative response in chronic hepatitis B carriers.

Jung MC, Grüner N, Zachoval R, Schraut W, Gerlach T, Diepolder H, Schirren CA, Page M, Bailey J, Birtles E, Whitehead E, Trojan J, Zeuzem S, Pape GR.

Vaccine. 2002 Oct 4;20(29-30):3598-612.

PMID:
12297407
49.

Typology of activity bouts and effect of fearfulness on behaviour in meat-type chickens.

Bizeray D, Leterrier C, Constantin P, Le Pape G, Faure JM.

Behav Processes. 2002 May 28;58(1-2):45-55.

PMID:
11955770
50.

Memory CD8+ T cells vary in differentiation phenotype in different persistent virus infections.

Appay V, Dunbar PR, Callan M, Klenerman P, Gillespie GM, Papagno L, Ogg GS, King A, Lechner F, Spina CA, Little S, Havlir DV, Richman DD, Gruener N, Pape G, Waters A, Easterbrook P, Salio M, Cerundolo V, McMichael AJ, Rowland-Jones SL.

Nat Med. 2002 Apr;8(4):379-85.

PMID:
11927944

Supplemental Content

Support Center